YTS109 cell

YTS109 · China Immunotech (Beijing) Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for YTS109 cell, covering 2025-05-13 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia [Phase 1]